ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2017

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Naoto Katakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.